You are here

Company Monitoring Page for JNJ

job ratings (see below graph) for JNJ

latest headlines for company on cafepharma

Report: Johnson & Johnson Has $4B Bids for Ortho Clinical

Wall St Cheat Sheet

Sun, 12/15/13 - 12:48 pm

Tags:

JNJ, Ortho Clinical Diagnostics, M&A

Celgene and Pharmacyclics Bring Big Change to Mantle Cell Lymphoma in 2013

Motley Fool

Sat, 12/14/13 - 12:03 pm

Tags:

Celgene Corporation, Pharmacyclics, mantle cell lymphoma, JNJ, Imbruvica, Revlimid

Novartis: 2 Novel Cancer Therapies Show Promising Results

Seeking Alpha

Wed, 12/11/13 - 02:42 pm

Tags:

Novartis, Celgene, JNJ, Merck, panobinostat, Multiple Myeloma, acute lymphocytic leukemia

What Is Johnson & Johnson's Opportunity In Hepatitis C Market?

Forbes

Wed, 12/11/13 - 09:01 am

Tags:

JNJ, hepatitis C, Olysio

J&J taps UK research hubs

The Telegraph, UK

Tue, 12/10/13 - 09:44 am

Tags:

EU regulators fine J&J, Novartis 16 mln euros for generic drug deal

Yahoo/Reuters

Tue, 12/10/13 - 09:25 am

Tags:

Europe, Novartis, generics, JNJ, Fentanyl

J&J, Roche, Novartis tout key cancer-drug data at ASH

Fierce Pharma

Mon, 12/9/13 - 10:12 am

Tags:

JNJ, Roche, Novartis, Imbruvica, Tasigna, CLL, Gazyva

How Risperdal Whistle-Blowers Made Millions From J&J

Bloomberg

Mon, 12/9/13 - 08:40 am

Tags:

Risperdal, JNJ, whistleblower lawsuits, whistleblowers

J&J’s Drug Shows Promise for Rare Castleman Disease

Bloomberg

Sun, 12/8/13 - 12:20 pm

Tags:

JNJ, siltuximab, multicentric Castleman disease

Johnson & Johnson Battles St. Jude for Cardiac Mapping Leadership

Motley Fool

Sat, 12/7/13 - 12:56 pm

Tags:

JNJ, St. Jude Medical, cardiac mapping

What Everybody Ought to Know About Gilead and Johnson & Johnson's New Hepatitis C Drugs

Seeking Alpha

Fri, 12/6/13 - 10:30 am

Tags:

JNJ, Gilead Sciences, hepatitis C, sofosbuvir, Olysio, AbbVie, Bristol-Myers Squibb, Merck

Large Study Finds Favorable Risk-Benefit Profile For The New Anticoagulants

Forbes

Thu, 12/5/13 - 06:45 pm

Tags:

bloodthinners, Pradaxa, Boehringer Ingelheim, Xarelto, JNJ, Eliquis, Pfizer, Bristol-Myers Squibb, edoxaban, Daiichi Sankyo

J&J Settles FDA Misbranding Case for $1.25 Million

Bloomberg

Thu, 12/5/13 - 08:28 am

Tags:

FDA, JNJ, misbranding, Advanced Sterilization Products, Sterrad Cyclesure 24

How The Global Pharma Industry Will Shape Up In The Next 5 Years?

Seeking Alpha

Wed, 12/4/13 - 11:38 am

Tags:

Bristol-Myers Squibb, GSK, JNJ, Ophthotech, Novartis, Regeneron, Roche, Sanofi

Johnson & Johnson Vs. Pfizer, Bristol In The Race Of Anticoagulants

Seeking Alpha

Tue, 12/3/13 - 11:01 am

Tags:

JNJ, bloodthinners, Pfizer, Bristol-Myers Squibb, Eliquis, Xarelto

Johnson & Johnson's Real Answer To Imminent Decline In Sales Of Top-Selling Drug

Seeking Alpha

Mon, 12/2/13 - 09:45 am

Tags:

JNJ, Remicade, Olysio, hepatitis C

J&J May Pay $1 Billion in Medical Costs Under Hip Accord

Bloomberg

Wed, 11/27/13 - 09:05 pm

Tags:

JNJ, hip implants, DePuy

Keep An Eye On GW, Johnson & Johnson, Durata, and Merck Today

Motley Fool

Wed, 11/27/13 - 09:58 am

Tags:

JNJ, Durata Therapeutics, Merck, GW Pharma, Olysio, Savitex, Noxafil, Dalvance

2014 FDA Drug Approval Decision Calendar

TheStreet.com

Wed, 11/27/13 - 08:39 am

Milestone payment triggers Genmab guidance increase

Yahoo/Reuters

Tue, 11/26/13 - 09:00 am

Tags:

Genmab, daratumumab, JNJ, Janssen

Pages

last 30 twitter posts